Showing results (1201-1210 of 1,893) with videos related to
Sort By:
Pageof 190
Immunotherapy|July 4, 2023
Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case reportMarco Infante, Laura Vitiello, Andrea Fabbri, et al.Immunotherapy|January 30, 2019
Intestinal microbiota predicts lung cancer patients at risk of immune-related diarrheaTian Liu, Qi Xiong, Lingling Li, et al.Immunotherapy|February 8, 2019
Heat-shock proteins in diagnosis and treatment: an overview of different biochemical and immunological functionsAlireza Milani, Marzieh Basirnejad, Azam BolhassaniImmunotherapy|January 31, 2019
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of actionNi Zhang, Jingyao Tu, Xue Wang, et al.Immunotherapy|September 9, 2020
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulinsJosé María Díez, Carolina Romero, Júlia Vergara-Alert, et al.Immunotherapy|March 17, 2020
Successful treatment of metastatic colorectal cancer with synchronous BRAF V600E mutation and dMMR with BGB-A317Yi Cheng, Xue-Feng Fang, Han-Guang Hu, et al.Immunotherapy|September 22, 2020
Omalizumab and adalimumab: a winning coupleLaura Diluvio, Laura Vollono, Arianna Zangrilli, et al.Immunotherapy|December 13, 2019
Abscopal effect in lung cancer: three case reports and a concise reviewElena Garelli, Achim Rittmeyer, Paul Martin Putora, et al.Immunotherapy|March 27, 2020
Exploiting antibody biology for the treatment of cancerVidhi Khanna, Jayanth Panyam, Thomas S GriffithImmunotherapy|March 28, 2020
Efficacy and safety of octanorm (cutaquig®) in adults with primary immunodeficiencies with predominant antibody deficiency: a prospective, open-label studyElena Latysheva, Yulia Rodina, Liudmila Sizyakina, et al.Pageof 190